Yihai Cao is a professor in medicine at the Karolinska Institutet, Stockholm, Sweden.  He is a member of Chinese Academy of Engineering, Academia Europaea, European Academy of Sciences and Arts,  National Academy of Inventors (US), and American Institute of Medicine and Biological Engineering (AIMBE). Yihai Cao received his medical training at the Shandong Medical School and his Ph.D. at the Karolinska Institute. He received his postdoctoral training in Dr. Judah Folkman’s laboratory at the Harvard Medical School. Cao’s laboratory has focused their interests on studying angiogenesis in tumor growth, metastasis, and non-malignant diseases. Through mechanistic studies, he aims to define novel therapeutic targets and resolve clinically unmet needs of antiangiogenic cancer therapy by proposing new concepts and paradigms. His research interests include molecular mechanisms of pathological angiogenesis contributing to obesity, metabolic diseases, diabetic complications, cancer, metastasis, and cardiovascular diseases, with emphasis on clinical relevance and translational research. He received an honorary medical doctor degree (M.D.) from Copenhagen University, Denmark in 2006. He is a guest professor at the Linköping University, Sweden; a guest professor at the Leicester University, UK; an honorary professor at the Copenhagen University, Denmark; and an honorary professor at the Shinshu University Japan. He received the Fernström research prize, the Axel Hirsch Prize in medicine, and a distinguished professor award at the Karolinska Institutet. Dr. Cao received an ERC-advanced research grant award and the distinguished NOVO Nordisk-advanced grant award. He has published more than 290 research articles. The average impact factor (IF) of his publications > 15.19 per article. According to Google Scholar, his scientific articles have been cited for more than 45470 times. H-index = 107.